NCT07572500

Brief Summary

The goal of the study is to compare deoxygenation events during anesthesia induction and mask ventilation when using standard oral pharyngeal airways or the novel distal pharyngeal airway.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
6mo left

Started Nov 2025

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Nov 2025Nov 2026

First Submitted

Initial submission to the registry

January 24, 2024

Completed
1.8 years until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

May 7, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

January 24, 2024

Last Update Submit

April 30, 2026

Conditions

Keywords

hypoxiahypoxicdesaturationdeoxygenationobstructive sleep apneaobesitymask ventilationoral pharyngeal airwaydistal pharyngeal airwayinductiondifficult airway

Outcome Measures

Primary Outcomes (1)

  • Number of participants with clinically significant hypoxia SpO2 < 92

    This outcome will be compared between two groups.

    Post-treatment recorded intra-operatively (up to 24 hours)

Secondary Outcomes (4)

  • Number of additional airway maneuvers used during bag-mask ventilation with the MEA DPA and OPA during induction of general anesthesia

    Post-treatment recorded intra-operatively (up to 24 hours)

  • Determine if additional airway maneuvers are used during bag-mask ventilation with the MEA DPA and OPA during induction of general anesthesia

    Post-treatment recorded intra-operatively (up to 24 hours)

  • Change in anesthesia provider satisfaction during anesthetic bag-mask ventilation (positive pressure ventilation)

    Immediately post-operatively (up to 24 hours)

  • Incidence of obstruction for sedated patients arriving in postoperative care with an airway in situ

    Immediately post-operatively (up to 24 hours)

Study Arms (2)

Novel DPA device

EXPERIMENTAL

Assess duration and severity of deoxygenation events with DPA use during anesthetic induction and mask ventilation.

Device: DPA

Standard OPA device

ACTIVE COMPARATOR

Assess duration and severity of deoxygenation events with OPA use during anesthetic induction and mask ventilation.

Device: OPA

Interventions

DPADEVICE

Anesthesiologist will use novel DPA device post anesthetic induction to assist in bag mask ventilation prior to endotracheal tube placement.

Novel DPA device
OPADEVICE

Anesthesiologist will use standard OPA device post anesthetic induction to assist in bag mask ventilation prior to endotracheal tube placement.

Standard OPA device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient presenting for surgery at main Stanford Hospital
  • Over 18 years old
  • ASA Class II, III, IV
  • High risk for hypoxic events during intubation based on their past medical history
  • BMI \>35
  • Likelihood of obstructive sleep apnea utilizing the STOP-BANG questionnaire
  • History of diagnosed sleep apnea
  • History of difficult intubation
  • Prior need for two-handed mask ventilation
  • Requiring general anesthesia with endotracheal intubation for surgery

You may not qualify if:

  • Altered mental status
  • Anesthesia technique includes rapid sequence or modified rapid sequence intubation
  • Poorly controlled gastroesophageal reflux

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypoxiaObesitySleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Comparison of two groups: 1) Oral pharyngeal airway (OPA) group 2) Distal pharyngeal airway (DPA) group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology, Perioperative and Pain Medicine

Study Record Dates

First Submitted

January 24, 2024

First Posted

May 7, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

May 7, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share